ARAY · Accuray Inc
$0.24
0.00 (-0.79%)
At close · Jul 24
View the 10-Q filed May 6, 2026
Customer concentration
— top customer 17% of revenue
One customer — 17% of revenue (the three months ended March 31, 2026)
“The JV represented approximately 17% and 21% of our total net revenue during the three months ended March 31, 2026 and 2025 respectively”
One customer — 16% of revenue (the nine months ended March 31, 2026)
“and represented approximately 16% and 27% of our total net revenue during the nine months ended March 31, 2026 and 2025 respectively.”
One customer — 13% of receivables (As of March 31, 2026)
“As of March 31, 2026, and June 30, 2025, the JV represented approximately 13% and 33%, respectively, of our total accounts receivable balance.”
Market Cap
$28.36M
Shares
118.96M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$458.51M
+2.7%
FY2025
Net Income
-$1.59M
+89.8%
FY2025
Gross Margin
32.05%
0pp
FY2025
Operating Margin
1.71%
+1.6pp
FY2025
Diluted EPS
-$0.02
+87.5%
FY2025
Operating Cash Flow
$2.86M
+124%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $471M – $485M | — | $458.51M | $446.55M | $447.61M | $429.91M | $396.29M | $382.93M | $418.79M | $404.9M | $383.41M | $398.8M | $379.8M | $369.42M | $315.97M | $409.22M | |
| — | — | $311.54M | $303.63M | $293.65M | $269.95M | $236.78M | $233.21M | $256.13M | $243.2M | $242.07M | $240.09M | $234.4M | $226.62M | $218.33M | $271.95M | |
| — | — | $146.97M | $142.92M | $153.96M | $159.96M | $159.51M | $149.72M | $162.65M | $161.7M | $141.34M | $158.71M | $145.4M | $142.8M | $97.64M | $137.27M | |
| — | — | 32.05% | 32.01% | 34.4% | 37.21% | 40.25% | 39.1% | 38.84% | 39.93% | 36.86% | 39.8% | 38.28% | 38.66% | 30.9% | 33.54% | |
| — | — | $47.94M | $49.73M | $57.13M | $57.75M | $52.73M | $49.78M | $56.49M | $57.25M | $49.92M | $56.65M | $55.75M | $53.72M | $66.2M | $87.11M | |
| — | — | $43.32M | $42.62M | $46.18M | $49.66M | $42.82M | $47.25M | $56M | $60.11M | $57.48M | $56.81M | $62.44M | $61.89M | $54.37M | $54.55M | |
| — | — | $47.87M | $50.07M | $48.27M | $44.39M | $41.72M | $40.14M | $49.58M | $48.14M | $43.77M | $50.12M | $46.38M | $45.34M | $57.73M | $58.6M | |
| — | — | $200K | $200K | $200K | $100K | $200K | $200K | $100K | $100K | $7.7M | $8M | $7.9M | $8.4M | $10.4M | $16.2M | |
| — | — | $6.15M | $5.91M | $4.53M | $5.51M | $6.39M | $7.54M | $10.49M | $9.73M | $18.04M | $18.3M | $19.49M | $20.56M | $25.56M | $32.59M | |
| — | — | — | $2.6M | $2.7M | — | — | — | — | — | — | — | $9.1M | $9.1M | $9.1M | — | |
| — | — | $139.13M | $142.42M | $151.58M | $151.81M | $137.27M | $137.18M | $162.07M | $165.49M | $151.16M | $163.59M | $164.57M | $160.94M | $178.3M | $200.26M | |
| — | — | $7.84M | $504K | $2.38M | $8.15M | $22.24M | $12.54M | $583K | -$3.8M | -$9.82M | -$4.87M | -$19.17M | -$18.14M | -$80.66M | -$62.99M | |
| — | — | 1.71% | 0.11% | 0.53% | 1.9% | 5.61% | 3.27% | 0.14% | -0.94% | -2.56% | -1.22% | -5.05% | -4.91% | -25.53% | -15.39% | |
| — | — | $13.99M | $6.41M | $6.91M | $13.66M | $28.62M | $20.08M | $11.07M | $5.94M | $8.22M | $13.42M | $324K | $2.42M | -$55.09M | -$30.4M | |
| — | — | $12.95M | $11.62M | $10.63M | $8.13M | $16.89M | $18.08M | — | — | — | — | — | — | — | — | |
| — | $988K | $1.19M | — | — | — | — | — | — | — | — | — | — | — | — | $360K | |
| — | — | $559K | -$2.54M | -$11.74M | -$10.39M | -$27.67M | -$6.7M | -$14.93M | -$19.22M | -$18.72M | $1.18M | -$448K | -$14.22M | -$13.13M | -$12.87M | |
| — | — | $4.71M | $1.84M | $2.57M | $241K | $12.96M | $12.96M | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | — | $1.13M | -$11.82M | -$6.79M | -$2M | -$4.56M | $5.69M | -$14.34M | -$23.02M | -$28.54M | -$23.17M | -$37.79M | -$32.36M | -$93.79M | -$75.86M | |
| — | — | $2.73M | $3.73M | $2.49M | $3.35M | $1.75M | $1.86M | $2.09M | $878K | $1.04M | $2.34M | $2.42M | $3.09M | $3.57M | $2.6M | |
| — | — | -$1.59M | -$15.55M | -$9.28M | -$5.35M | -$6.31M | $3.83M | -$16.43M | -$23.9M | -$29.58M | -$25.5M | -$40.21M | -$9.81M | -$116.51M | -$78.45M | |
| — | — | -0.35% | -3.48% | -2.07% | -1.24% | -1.59% | 1% | -3.92% | -5.9% | -7.71% | -6.4% | -10.59% | -2.66% | -36.87% | -19.17% | |
| — | -$16.94M | — | — | — | — | — | — | — | — | — | — | — | — | — | -$6.41M | |
| — | — | -$1.59M | — | — | — | — | — | — | — | -$29.58M | -$25.5M | -$40.21M | -$35.45M | -$103.22M | -$72.04M | |
| — | — | $794K | -$20.19M | -$11.26M | -$5.03M | -$3.73M | $3.35M | -$17.53M | -$22.75M | -$28.67M | -$26.04M | -$42.45M | -$35.52M | — | — | |
| USD/shares | — | — | -$0.02 | -$0.16 | -$0.10 | -$0.06 | -$0.07 | $0.04 | — | — | -$0.09 | -$0.09 | — | — | — | -$1.02 |
| USD/shares | — | — | -$0.02 | -$0.16 | -$0.10 | -$0.06 | -$0.07 | $0.04 | — | — | -$0.09 | -$0.09 | — | — | — | -$1.02 |
| shares | — | — | 102.77M | 98.27M | 94.88M | 92.1M | 92.03M | 89.87M | 87.47M | 84.89M | 82.5M | 80.51M | 78.28M | 75.8M | 73.28M | 70.89M |
| shares | — | — | 102.77M | 98.27M | 94.88M | 92.1M | 92.03M | 90.62M | 87.47M | 84.89M | 82.5M | 80.51M | 78.28M | 75.8M | 73.28M | 70.89M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2023: $14.08M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.32×
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.03×
P/E (TTM)
—
Medical Devices median 27.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Eimea | $144,264,000 | $168,611,000 | — | — | — | — | — | — |
| China | $124,475,000 | $103,412,000 | $75,762,000 | $86,935,000 | $79,782,000 | $30,392,000 | $19,657,000 | — |
| Americas | $88,768,000 | $90,156,000 | $122,335,000 | $126,005,000 | $105,878,000 | $128,562,000 | $135,683,000 | $145,689,000 |
| Japan | $53,622,000 | $55,682,000 | $61,962,000 | $53,376,000 | $62,636,000 | $72,688,000 | $70,214,000 | $66,251,000 |
| Asia Pacific | $47,376,000 | $28,690,000 | — | — | — | — | — | — |
| Asia Excluding Japan and India | — | — | — | — | — | — | — | $72,925,000 |
| Asia Pacific Excluding China | — | — | $31,667,000 | $28,953,000 | — | — | — | — |
| Asia Pacific Excluding Japan and China | — | — | — | — | $26,425,000 | $31,297,000 | $44,136,000 | — |
| Europe India Middle East and Africa | — | — | $155,879,000 | $134,640,000 | $121,568,000 | $119,989,000 | $149,095,000 | $120,032,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product | $237,580,000 | $234,164,000 | $233,192,000 | $214,715,000 | $176,647,000 | $167,302,000 | $196,665,000 | $183,898,000 |
| Service | $220,925,000 | $212,387,000 | $214,413,000 | $215,194,000 | $219,642,000 | $215,626,000 | $222,120,000 | $220,999,000 |
Key facts
CIK
1138723
CUSIP
004397105
13F (30d)
17 filings
17 filers
Visit website
Investor relations